The very fast transient overvoltage (VFTO) generated during switching of the disconnector (DS) in gas-insulated switchgear (GIS) may threaten the insulation of electrical equipment. DS characteristics ...

ASCO 2025 phase 1b/2 study assessing 9MW2821, nectin-4 antibody drug conjugate, toripalimab in treatment-naïve patients, locally advanced or metastatic urothelial carcinoma.

Pedro Valencia, VP, asset strategy, leadership, oncology, AbbVie, outlines how the company is accelerating development across lung, gastrointestinal, and ovarian cancers following ASCO 2025, with a ...

Findings seen in women with moderate-to-severe vasomotor symptoms associated with endocrine therapy for HR-positive breast cancer.

Terms and definitions encompassing products within the scope of ac (48.3 kV and below for air insulated equipment, 52 kV and below for gas insulated equipment) and dc (3.2 kV and below) power ...

ASCO convened an Expert Panel to update the 2020 guideline on systemic therapy for HCC. The panel updated the systematic review to include randomized controlled trials (RCTs) published through October ...

Updates in metastatic NSCLC from ASCO 2025 include data from TROPION-Lung02 on Dato-DXd, KRYSTAL-7 on first-line adagrasib, and zipalertinib from REZILIENT1, presented by Dr Jonathan Goldman.

ASCO 2025, prostate cancer, metastatic castration-resistant prostate cancer (mCRPC), Pasritamig, JNJ-78278343, KLK2 gene, dexamethasone.

The de-escalation of therapy helps avoid unnecessary toxicity from treatment in patients with brain cancer, explained Drs. Joshua K. Sabari and Manmeet Singh Ahluwalia.

In the article that accompanies this editorial, Babiker et al 12 present the data that tumor-treating fields (TTFs) combined with gemcitabine plus nab-paclitaxel improved median overall survival ...

Logistics firm ASCO has landed a North Sea contract worth “approximately £150 million”, with work set to kick off in July.